BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Stem Cell News » Press Releases » Page 2

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

April 25, 2022 By Cade Hildreth (CEO) Leave a Comment

Direct Biologics ExoFlow

AUSTIN, Texas, April 21, 2022 – Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo, to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19. Direct Biologics is the first and only EV company to receive FDA Phase 3 approval for an Investigational New Drug (IND) indication to date.
[Read more…]

Filed Under: Exosomes, Press Releases

AASCP is Proud to Add Dr. Scheffer Tseng, Accalimed Opthamologist and Founder of Bio-Tissue Products, to Its Speaker Roster

April 25, 2022 By Cade Hildreth (CEO) Leave a Comment

AASCP Dr Scheffer Tseng Bio-Tissue
The American Academy of Stem Cell Physicians (AASCP) will meet on June 17-19, 2022, and be offering hands on workshops.

MIAMI, April 27, 2022 – The American Academy of Stem Cell Physicians (AASCP) is proud to welcome the acclaimed Ophthalmologist Dr. Scheffer Tseng as a Guest Speaker for its upcoming conference on June 17-19, 2022 in Miami, Florida. At this event, the AASCP will host expert speakers from across the country lecturing on the innovations in stem cell research and how they can be safely and effectively applied to patient populations in accordance with current regulations. Hands on workshops will also be offered. [Read more…]

Filed Under: Press Releases, Stem Cell News

TreeFrog Therapeutics Launches a $100,000 Research Grant in Regenerative Medicine

April 19, 2022 By Cade Hildreth (CEO) Leave a Comment

TreeFrog Therapeutics Spaceshot Grant

Bordeaux, France / April 19th, 2022 – TreeFrog Therapeutics, a biotechnology company aimed at making safer, more efficient and more affordable cell therapies based on induced pluripotent stem cells (iPSCs), today announced the launch of The Stem Cell SpaceShot Grant, a $100,000 research funding in the field of stem cell biology and regenerative medicine. [Read more…]

Filed Under: iPS Cells, Press Releases, Stem Cell News

Treefrog Therapeutics Expands Board with New Independent Members from the Cell Therapy Industy

April 14, 2022 By Cade Hildreth (CEO) Leave a Comment

Treefrog Therapeutics Expands Board
• Elsy Boglioli, former Chief Operating Officer at French cell therapy biotech Cellectis, founder and Chief Executive Officer of biotechnology consulting practice Bio-Up, joins as Chair of the Board
• Melissa Carpenter, PhD, Chief Scientific Officer of US-based cell & gene therapy biotech ElevateBio’s Regenerative Medicine unit, joins as independent board member.

[Read more…]

Filed Under: Cell Therapy, iPS Cells, Press Releases, Stem Cell News, Stem Cells

AASCP Confirms Joseph Purita, MD, as Keynote Speaker for Its Upcoming Meeting on June 17-19 in Miami, Florida

April 13, 2022 By Cade Hildreth (CEO) Leave a Comment

aascp-joseph-purita-md
Speakers at the AASCP’s annual conference are experts from across the country in stem cell research, lecturing on the recent innovations.

April 16, 2022, MIAMI, Florida – The American Academy of Stem Cells Physicians will be back at the Hyatt Hotel for its annual conference this June 17-19, 2022. The Academy is honored to confirm Dr. Joseph Purita, one of the most well known experts within the regenerative field, for the event. “The Academy is proud to offer state-of-the-art Regenerative workshops, lead by leaders with over 100 years of combined experience,” said Dr. Sunny Kim, President of the AASCP. [Read more…]

Filed Under: Press Releases

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 65
  • Next Page »

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97

Featured Posts

PolarityTE RMAT

PolarityTE Announces FDA RMAT Awarded to Its Designation Granted to SkinTE®

Advanced Therapy | What is a RMAT Designation (and Who Has One)?

What Is An RMAT? List of Publicly Announced RMAT Designations (64)

i-peaces-cell-manufacturing

I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.